2024 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
Chairmain of the Board, President and Chief Execut |
- |
- |
2024 |
NovoCure Ltd
|
Independent Director |
- |
- |
2023 |
NovoCure Ltd
|
Independent Director |
426.1 K |
0.2 % |
2023 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
President, Chief Executive Officer and Director |
- |
- |
2022 |
NovoCure Ltd
|
Independent Director |
425.1 K |
7.7 % |
2022 |
Nuvation Bio Inc - Warrants (07/07/2027)
|
President, Chief Executive Officer and Director |
- |
- |
2021 |
NovoCure Ltd
|
Independent Director |
394.8 K |
-0.6 % |
2021 |
Nuvation Bio Inc - Ordinary Shares - Class A
|
President, Chief Executive Officer and Director |
- |
- |
2021 |
Establishment Labs Holdings Inc
|
Independent Director |
- |
- |
2020 |
NovoCure Ltd
|
Independent Director |
397.1 K |
-0.1 % |
2020 |
Establishment Labs Holdings Inc
|
Independent Director |
134.1 K |
-51.2 % |
2019 |
NovoCure Ltd
|
Independent Director |
397.5 K |
-48.9 % |
2019 |
Establishment Labs Holdings Inc
|
Independent Director |
274.7 K |
1302.1 % |
2019 |
Immatics N.V
|
Independent Director |
- |
- |
2018 |
NovoCure Ltd
|
Independent Director |
777.2 K |
- |
2018 |
Establishment Labs Holdings Inc
|
Independent Director |
19.6 K |
- |
2017 |
Establishment Labs Holdings Inc
|
Independent Director |
- |
- |
2017 |
NovoCure Ltd
|
Independent Director |
- |
- |